FrancophonIA/ELRC3.0 huggingface dataset:
English: These symptoms included sweating, trembling, dizziness, increased appetite, palpitations, nausea, fatigue, and weakness.
Slovenian: Ti simptomi so zajemali znojenje, tresenje, vrtoglavost, povečan tek, palpitacije, navzejo, utrujenost in oslabelost.
English: Although safety was not compromised in this population dose adjustment may be required in view of low Cmax.
Slovenian: Čeprav v tej skupini varnost ni bila ogrožena, je lahko potrebno zaradi nizke Cmax prilagoditi odmerek.
English: Watch carefully for signs of low blood sugar, especially if you have exercised more strenuously than usual.
Slovenian: Bodite pozorni na znake nizkega krvnega sladkorja, zlasti še - če ste se pri telesni aktivnosti bolj naprezali kot navadno, - če ste pili alkohol.
English: In completed clinical trials, symptoms of hypoglycaemia were reported in 10.4% with nateglinide monotherapy, 14.5% with nateglinide+metformin combination, 6.9% with metformin alone, 19.8% with glibenclamide alone,
Slovenian: V končanih kliničnih preskušanjih so o simptomih hipoglikemije poročali pri monoterapiji z nateglinidom pri 10,4 %, pri kombinaciji nateglinida in metformina pri 14,5 %, pri samem metforminu pri 6,9 %, pri samem glibenklamidu pri 19,8 % in pri placebu pri 4,1 %.
English: The steady-state volume of distribution of nateglinide based on intravenous data is estimated to be approximately 10 litres.
Slovenian: Ocenjujejo, da je porazdelitveni prostor nateglinida v stanju dinamičnega ravnovesja na podlagi intravenskih podatkov okrog 10 litrov.
English: No clinical studies have been conducted in patients with severe hepatic impairment or children and adolescents.
Slovenian: Pri bolnikih s hudo jetrno okvaro ter pri otrocih in mladostnikih niso bile opravljene klinične raziskave.
English: This is particularly important if you have reduced or absent awareness of the warning signs of hypoglycaemia or if you have frequent episodes of hypoglycaemia.
Slovenian: To je zlasti pomembno, če se manj ali sploh ne zavedate svarilnih znakov hipoglikemije ali če imate pogoste epizode hipoglikemije.
English: Consistent with its short elimination half-life, there is no apparent accumulation of nateglinide upon multiple dosing with up to 240 mg three times daily.
Slovenian: V skladu s kratkim razpolovnim časom se nateglinid po večkratnem odmerjanju z do 240 mg trikrat na dan ne akumulira v telesu.
English: Trazec and older people Trazec can be used by people over 65 years of age.
Slovenian: Trazec lahko uporabljajo tudi ljudje, starejši od 65 let.
English: In combination with metformin, which mainly affected fasting plasma glucose, the effect of nateglinide on HbA1c was additive compared to either agent alone.
Slovenian: V kombinaciji z metforminom, ki je vplival predvsem na plazemsko glukozo na tešče, je bil učinek nateglinida na HbA1c aditiven, če ga primerjamo z vsako od obeh snovi posebej.
English: Nateglinide-induced insulin secretion by pancreatic beta cells is glucose-sensitive, such that less insulin is secreted as glucose levels fall.
Slovenian: Sekrecija insulina iz pankreatičnih celic beta, ki jo povzroči nateglinid, je občutljiva za glukozo, tako da se izloča manj insulina, ko koncentracija glukoze pada.
English: If you do get symptoms of low blood sugar, eat or drink something containing sugar and talk to your doctor.
Slovenian: Če dobite simptome nizkega krvnega sladkorja, pojejte ali popijte nekaj kar vsebuje sladkor in se pogovorite z zdravnikom.
English: The decrease from baseline in HbA1c was -0.41% in the nateglinide plus metformin group and -0.57% in the gliclazide plus metformin group (difference 0.17%, [95% CI -0.03, 0.36]).
Slovenian: HbA1c se je zmanjšal od izhodišča za0,41 % v skupini z nateglinidom plus metforminom in za -0,57 % v skupini z gliklazidom plus metforminom (razlika 0,17 %, [95-odstotni interval zaupanja -0,03, 0,36]).
English: Patients should be advised to take precautions to avoid hypoglycaemia whilst driving or operating machinery.
Slovenian: Bolnikom morate svetovati, naj se s previdnostnimi ukrepi izognejo hipoglikemiji tačas ko vozijo ali upravljajo s stroji.
English: Insulin levels return to baseline within 3 to 4 hours, reducing post-meal
Slovenian: Koncentracija insulina se vrne na izhodiščno vrednost v 3 do 4 urah, kar zmanjša postprandialno hiperinsulinemijo.
English: Nateglinide is rapidly absorbed following oral administration of Trazec tablets prior to a meal, with mean peak drug concentration generally occurring in less than 1 hour.
Slovenian: Nateglinid se po peroralnem zaužitju tablet Trazec pred obrokom hitro absorbira, povprečna najvišja koncentracija zdravila se običajno pojavi v manj kot 1 uri.
English: Nateglinide is indicated for combination therapy with metformin in type 2 diabetic patients inadequately controlled despite a maximally tolerated dose of metformin alone.
Slovenian: Nateglinid je indiciran za kombinirano zdravljenje z metforminom pri bolnikih s sladkorno boleznijo tipa 2, ki niso ustrezno kontrolirani kljub največjemu odmerku metformina samega, ki ga lahko prenašajo.
English: Based on the experience with nateglinide and with other hypoglycaemic agents, the following adverse reactions have been seen.
Slovenian: Na podlagi izkušenj z nateglinidom in drugimi hipoglikemičnimi sredstvi so bili ugotovljeni spodaj navedeni neželeni učinki.
English: Your doctor will determine the dosage you require.
Slovenian: Vaš zdravnik bo določil odmerjanje, ki je za vas najbolj primerno.
English: Early insulin secretion is a mechanism for the maintenance of normal glycaemic control.
Slovenian: Zgodnja sekrecija insulina je mehanizem za vzdrževanje normalnega uravnavanja koncentracije glukoze v krvi.
English: Patients with rare hereditary problems of galactose intolerance, of the Lapp lactase deficiency or of glucose-galactose malabsorption should not take this medicine.
Slovenian: Bolniki z redkimi prirojenimi motnjami kot so intoleranca za galaktozo, laponska oblika zmanjšane aktivnosti laktaze ali malabsorpcija glukoze/galaktoze, ne smejo jemati tega zdravila.
English: A very rare effect is skin rash with blisters affecting the lips, eyes, mouth, sometimes with headache,
Slovenian: Zelo redek učinek je kožni izpuščaj z mehurčki na ustnicah, očeh in v ustih, včasih z glavobolom, zvišano telesno temperaturo in/ali drisko.
English: If you do get symptoms of low blood sugar, eat or drink something containing sugar.
Slovenian: Če dobite simptome nizkega krvnega sladkorja, pojejte ali popijte nekaj kar vsebuje sladkor.
English: Since the primary therapeutic effect of Trazec is to reduce mealtime glucose, (a contributor to HbA1c), the therapeutic response to Trazec may also be monitored with 1-2 hour post-meal glucose.
Slovenian: Ker je primarni terapevtski učinek Trazeca zniževanje glukoze v času obroka (ki je eden od dejavnikov, ki prispevajo k HbA1c), lahko terapevtski odziv na Trazec spremljamo tudi z glukozo 1-2 uri po obroku.
English: The extent of serum protein binding is independent of drug concentration over the test range of 0.1-10 μg Trazec/ml.
Slovenian: Stopnja vezave na serumske beljakovine je v mejah testiranja od 0,1 do 10 µg Trazeca/ml neodvisna od koncentracije zdravila.
English: Nateglinide has shown a low potential for protein displacement in in vitro studies.
Slovenian: V raziskavah in vitro je nateglinid pokazal le majhen potencial za izpodrivanje beljakovin.
English: If you have accidentally taken too many tablets, talk to a doctor straight away.
Slovenian: Če ste vzeli večji odmerek zdravila Trazec, kot bi smeli Če ste pomotoma vzeli preveč tablet, se nemudoma posvetujte z zdravnikom.
English: This is particularly important in those who have reduced or absent awareness of the warning signs of hypoglycaemia or have frequent episodes of hypoglycaemia.
Slovenian: To je posebno pomembno za tiste, ki se manj ali sploh ne zavedajo svarilnih znakov hipoglikemije ali imajo pogoste epizode hipoglikemije.
English: This results in a blood-glucose-lowering effect throughout the meal period.
Slovenian: To povzroči hipoglikemični učinek, ki traja ves čas obroka.
English: Nateglinide closes ATP-dependent potassium channels in the beta-cell membrane with characteristics that distinguish it from other sulphonylurea receptor ligands.
Slovenian: Nateglinid zapira od ATP odvisne kalijeve kanalčke v membrani celice beta z značilnostmi, ki ga ločijo od drugih ligandov za receptorje za sulfonilsečnino.
English: When these medicinal products are administered to or withdrawn from patients receiving nateglinide, the patient should be observed closely for changes in glycaemic control.
Slovenian: Kadar so bolniku, ki jemlje nateglinid, predpisana ali ukinjena ta zdravila, ga je treba natančno opazovati glede sprememb glikemične kontrole.
English: If you get any of these symptoms - feeling dizzy, light-headed, hungry, shaky or any of the other signs in section 4, “Possible side effects” - eat or drink something containing sugar.
Slovenian: Če dobite enega ali več od teh simptomov - občutek vrtoglavosti, omotičnosti, lakote, tresenje ali kak drug znak iz poglavja 4, “Možni neželeni učinki” - pojejte ali popijte nekaj kar vsebuje sladkor.
English: As nateglinide is highly protein-bound, dialysis is not an efficient means of
Slovenian: Ker je nateglinid v veliki meri vezan na beljakovine, dializa ni učinkovito sredstvo za odstranjevanje tega zdravila iz krvi.
English: Preclinical data revealed no special hazard for humans based on conventional studies of safety pharmacology, repeated dose toxicity, genotoxicity, carcinogenic potential and toxicity to fertility and post-natal development.
Slovenian: Predklinični podatki na osnovi običajnih študij farmakološke varnosti, toksičnosti pri ponavljajočih se odmerkih, genotoksičnosti, kancerogenega potenciala in toksičnosti za plodnost in postnatalni razvoj ne kažejo posebnega tveganja za človeka.
English: The advisability of driving should be considered in these circumstances.
Slovenian: V teh okoliščinah je treba pretehtati, ali je upravljanje motornega vozila sploh priporočljivo.
English: In vivo, nateglinide has no clinically relevant effect on the pharmacokinetics of medicinal products metabolised by CYP2C9 and CYP3A4.
Slovenian: In vivo nateglinid nima klinično pomembnega učinka na farmakokinetiko zdravil, ki jih presnavljata CYP2C9 in CYP3A4.
English: • CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE IMPOSED ON Medicinal product subject to medical prescription
Slovenian: B. POGOJI DOVOLJENJA ZA PROMET Z ZDRAVILOM • POGOJI ALI OMEJITVE GLEDE OSKRBE IN UPORABE, PREDPISANI IMETNIKU
English: The systemic availability and half-life in dialysis-dependent diabetic patients was comparable with healthy subjects.
Slovenian: Sistemska uporabnost in razpolovni čas pri sladkornih bolnikih, odvisnih od dialize, sta bila primerljiva s tistima pri zdravih osebah.
English: Gender: No clinically significant differences in nateglinide pharmacokinetics were observed between
Slovenian: Spol: med moškimi in ženskami niso opažene klinično pomembne razlike v farmakokinetiki nateglinida.
English: Lactose monohydrate: 141.5 mg per tablet.
Slovenian: Pomožne snovi: laktoza monohidrat: 141,5 mg na tableto.
English: The resulting calcium influx enhances insulin secretion.
Slovenian: Posledični vstop kalcija poveča sekrecijo insulina.
English: Nateglinide is a rapid, short-acting oral insulin secretagogue.
Slovenian: Nateglinid je hitro in kratkotrajno delujoč peroralen sekretagog insulina.
English: Renal impairment: The systemic availability and half-life of nateglinide in diabetic patients with mild, moderate (creatinine clearance 31-50 ml/min) and severe (creatinine clearance 15-30 ml/min) renal impairment (not undergoing dialysis) did not differ to a clinically significant degree from those in healthy subjects.
Slovenian: Ledvična okvara: sistemska uporabnost in razpolovni čas nateglinida pri sladkornih bolnikih z blago, zmerno (očistek kreatinina 31-50 ml/min) in hudo (očistek kreatinina 15-30 ml/min) okvaro ledvic (ki niso na dializi), se nista razlikovala v klinično značilni meri od tistih pri zdravih osebah.
English: Although there is a 49% decrease in Cmax of nateglinide in dialysis patients, the systemic availability and half-life in diabetic subjects with moderate to severe renal insufficiency (creatinine clearance 15-50 ml/min) was comparable between renal subjects requiring haemodialysis and healthy subjects.
Slovenian: Čeprav se pri dializnih bolnikih Cmax nateglinida zmanjša za 49 %, sta bila sistemska uporabnost in razpolovni čas pri sladkornih bolnikih z zmerno do hudo ledvično insuficienco (očistek kreatinina 15-50 ml/min) pri ledvičnih bolnikih, ki potrebujejo hemodializo, in pri zdravih osebah primerljiva.
English: In rabbits, at maternally toxic doses a higher incidence of foetuses with no gallbladder was observed.
Slovenian: Pri kuncih je bila pri odmerkih, toksičnih za mater, opažena večja pogostost plodov brez žolčnika.
English: The side effects caused by Trazec are usually mild to moderate.
Slovenian: Neželeni učinki, ki jih povzroča Trazec, so navadno blagi do zmerni.
English: Conversely, the coadministration of food or a glucose infusion results in an enhancement of insulin secretion.
Slovenian: Obratno sočasno dajanje hrane ali infuzije glukoze povzroči povečanje sekrecije insulina.
English: Rare effects are mild abnormalities in liver function tests and allergic (hypersensitivity) reactions such
Slovenian: Redki učinki so blage nenormalnosti testov jetrnih funkcij in alergijske (preobčutljivostne) reakcije, na primer izpuščaj in srbenje.
English: Trazec contains lactose monohydrate.
Slovenian: Trazec vsebuje laktozo monohidrat.
English: Particular caution is recommended when nateglinide is co-administered with other more potent inhibitors of CYP2C9, e.g. fluconazole or gemfibrozil, or in patients known to be poor metabolisers
Slovenian: Posebna previdnost je potrebna pri sočasni uporabi nateglinida z drugimi močnejšimi inhibitorji CYP2C9, na primer s flukonazolom ali gemfibrozilom, ali pri bolnikih, za katere je znano, da imajo počasno presnovo, ki jo posreduje CYP2C9.
English: The other ingredients are lactose monohydrate; cellulose, microcrystalline; povidone; croscarmellose sodium; magnesium stearate and silica, colloidal anhydrous.
Slovenian: - Pomožne snovi so laktoza monohidrat; mikrokristalna celuloza; povidon; premrežen natrijev karmelozat; magnezijev stearat in brezvodni koloidni silicijev dioksid.
English: Do not use Trazec after the expiry date stated on the carton after EXP.
Slovenian: Zdravila Trazec ne smete uporabljati po datumu izteka roka uporabnosti, ki je naveden na škatli poleg oznake EXP. Datum izteka roka uporabnosti se nanaša na zadnji dan navedenega meseca.
English: Nateglinide is extensively metabolised.
Slovenian: Nateglinid se v veliki meri presnavlja.
English: Combination with metformin is associated with an increased risk of hypoglycaemia compared to
Slovenian: Pri kombinaciji z metforminom je nevarnost hipoglikemije večja kot pri monoterapiji.
English: Others
Slovenian: Drugi
English: It is especially important that you tell your doctor or pharmacist if you are taking: Beta blockers or angiotensin-converting enzyme inhibitors (used, for example, to treat high blood pressure and certain heart conditions).
Slovenian: Zelo pomembno je, da obvestite svojega zdravnika ali farmacevta, če jemljete: - zaviralce adrenergičnih receptorjev beta ali zaviralce angiotenzinske konvertaze (ki se uporabljajo na primer za zdravljenje visokega krvnega tlaka in nekaterih bolezni srca); - diuretike (uporabljajo se za zdravljenje visokega krvnega tlaka); - kortikosteroide, na primer prednizon in kortizon (uporabljajo se za zdravljenje vnetnih bolezni); - zaviralce presnove zdravil, na primer flukonazol (uporablja se za zdravljenje glivičnih okužb),
English: Similarly, there was no clinically significant pharmacokinetic interaction of Trazec with other oral antidiabetic agents such as metformin
Slovenian: Prav tako ni bilo klinično pomembnih farmakokinetičnih interakcij Trazeca z drugimi peroralnimi antidiabetiki, na primer z metforminom ali glibenklamidom.
English: Hepatic impairment: The systemic availability and half-life of nateglinide in non-diabetic subjects with mild to moderate hepatic impairment did not differ to a clinically significant degree from those in
Slovenian: Jetrna okvara: sistemska uporabnost in razpolovni čas nateglinida pri nediabetikih z blago do zmerno jetrno okvaro se nista razlikovala v klinično pomembni meri od tistih pri zdravih osebah.
English: The most common side effects are symptoms of low blood sugar (hypoglycaemia), which are usually
Slovenian: Najpogostejši neželeni učinki so navadno blagi simptomi nizkega krvnega sladkorja (hipoglikemije).
English: Data available from both in vitro and in vivo experiments indicate that nateglinide is predominantly metabolised by CYP2C9 with involvement of CYP3A4 to a smaller extent.
Slovenian: Podatki, ki so na razpolago iz poskusov in vitro kot tudi in vivo, kažejo, da nateglinid pretežno presnavlja CYP2C9, medtem ko CYP3A4 sodeluje v manjšem obsegu.
English: If you experience symptoms of low blood sugar - if you feel dizzy, light-headed, hungry, shaky, or any of the other signs in section 4, “Possible side effects” - eat or drink something containing sugar.
Slovenian: Če opazite simptome nizkega krvnega sladkorja - občutek vrtoglavosti, omotičnosti, lakote, tresenje ali kak drug znak iz poglavja 4, “Možni neželeni učinki” - pojejte ali popijte nekaj kar vsebuje sladkor.
English: The following agents may enhance the hypoglycaemic effect of nateglinide: angiotensin-converting enzyme inhibitors (ACEI).
Slovenian: Hipoglikemično delovanje nateglinida lahko povečajo zaviralci angiotenzinske konvertaze (ACEI).
English: The recommended maximum daily dose is 180 mg three times daily to be taken before the three main
Slovenian: Največji priporočeni dnevni odmerek je 180 mg trikrat na dan, vzame se ga pred tremi glavnimi obroki.
English: Not all pack sizes or tablet strengths may be
Slovenian: Morda vse velikosti pakiranj ali vse jakosti tablet niso na voljo v vaši državi.
English: As with other antidiabetic agents, symptoms suggestive of hypoglycaemia have been observed after administration of nateglinide.
Slovenian: Tako kot pri drugih antidiabetikih so bili opaženi tudi po uporabi nateglinida simptomi, ki kažejo na hipoglikemijo.
English: Trazec 60 mgfilm-coated tablets Trazec 120 mg film-coated tablets Trazec 180 mg film-coated tablets Nateglinide
Slovenian: Trazec 60 mg filmsko obložene tablete Trazec 120 mg filmsko obložene tablete Trazec 180 mg filmsko obložene tablete nateglinid
English: Common: Abdominal pain, diarrhoea, dyspepsia, nausea.
Slovenian: Pogosti: bolečine v trebuhu, driska, dispepsija, navzea.
English: Elderly: Age did not influence the pharmacokinetic properties of nateglinide.
Slovenian: Podskupine Starejši bolniki: starost ni vplivala na farmakokinetične lastnosti nateglinida.
English: 4.5 Interaction with other medicinal products and other forms of interaction A number of medicinal products influence glucose metabolism and possible interactions should therefore be taken into account by the physician:
Slovenian: Več zdravil vpliva na presnovo glukoze, zato mora zdravnik upoštevati možne interakcije:
English: Follow all instructions given to you by your doctor and pharmacist carefully, even if they are different if you are allergic (hypersensitive) to nateglinide or any of the other ingredients of Trazec.
Slovenian: Skrbno se ravnajte po vseh navodilih, ki vam jih je dal vaš zdravnik ali farmacevt, tudi če se razlikujejo od informacij v tem navodilu za uporabo.
English: There is no experience of an overdose of Trazec in clinical trials.
Slovenian: S prevelikim odmerjanjem Trazeca v kliničnih preskušanjih ni izkušenj.
English: Like other insulin secretagogues, nateglinide is capable of producing hypoglycaemia.
Slovenian: Podobno kot drugi insulinski sekretagogi lahko tudi nateglinid povzroča hipoglikemijo.
English: The pharmacokinetics of warfarin (a substrate for CYP3A4 and CYP2C9), diclofenac (a substrate for CYP2C9), and digoxin were unaffected by coadministration with nateglinide.
Slovenian: Sočasna uporaba z nateglinidom ni vplivala na farmakokinetiko varfarina (substrat za CYP3A4 in CYP2C9), diklofenaka (substrat za CYP2C9) in digoksina.
English: People with diabetes sometimes get symptoms of low blood sugar (also called hypoglycaemia).
Slovenian: Bodite posebno pozorni pri jemanju zdravila Trazec Ljudje s sladkorno boleznijo včasih dobijo simptome znižanega krvnega sladkorja (imenuje se tudi hipoglikemija).
English: Other adverse events observed in clinical studies were of a similar incidence in Trazec-treated and
Slovenian: Drugi neželeni učinki, ki so bili opaženi v kliničnih študijah, so se pojavljali podobno pogosto pri bolnikih, ki so dobivali bodisi Trazec bodisi placebo.
English: Thus, no dosage adjustment is required for digoxin, warfarin or other drugs that are CYP2C9 or CYP3A4 substrates upon coadministration with Trazec.
Slovenian: Zato pri sočasni uporabi s Trazecom pri digoksinu, varfarinu in drugih zdravilih, ki so substrati CYP2C9 ali CYP3A4, ni potrebno prilagajanje odmerjanja.
English: Nateglinide is an amino acid (phenylalanine) derivative, which is chemically and pharmacologically distinct from other antidiabetic agents.
Slovenian: Farmakoterapevtska skupina: derivati D-fenilalanina, oznaka ATC: A10 BX 03 Nateglinid je derivat aminokisline (fenilalanina), ki se kemijsko in farmakološko razlikuje od drugih antidiabetikov.
English: If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please
Slovenian: - Če katerikoli neželeni učinek postane resen ali če opazite katerikoli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
English: 6.2 Incompatibilities Not applicable 6.3 Shelf life 3 years
Slovenian: 6.3 Rok uporabnosti
English: • CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND
Slovenian: • POGOJI ALI OMEJITVE GLEDE VARNE IN UČINKOVITE UPORABE ZDRAVILA Navedba smiselno ni potrebna.
English: Although safety was not compromised in this population dose adjustment may
Slovenian: Čeprav varnost pri tej skupini ni bila ogrožena, se lahko zaradi nizke Cmax prilagodi odmerek.
English: The tablet coating contains hypromellose; titanium dioxide (E171); talc; macrogol and red (60 and 180 mg tablets) or yellow (120 mg tablets) iron oxide (E172).
Slovenian: - Obloga tablete vsebuje hipromelozo; titanov dioksid (E171); smukec; makrogol in rdeči (60 in
English: Its effect may be delayed if it is taken
Slovenian: Če ga boste jemali med obroki ali po njih, utegne biti njegov učinek zapoznel.
English: You are advised to take precautions to avoid hypoglycaemia whilst driving.
Slovenian: Vpliv na sposobnost upravljanja vozil in strojev Svetujemo vam, da se s previdnostnimi ukrepi izognete hipoglikemiji, medtem ko vozite.
English: if you know that you have a severe liver problem.
Slovenian: • s hudo jetrno okvaro.
English: The expiry date refers to the Do not use any Trazec pack that is damaged or shows signs of tampering.
Slovenian: Ne uporabite Trazeca, če je ovojnina poškodovana ali kaže znake, da jo je nekdo že odprl.
English: The main metabolites found in humans result from hydroxylation of the isopropyl side-chain, either on the methine carbon, or one of the methyl groups; activity of the main metabolites is about 5-6 and 3 times less potent than nateglinide, respectively.
Slovenian: Poglavitna presnovka, ki ju najdemo pri ljudeh, nastaneta s hidroksilacijo izopropilne stranske verige, bodisi na metinskem ogljiku bodisi na eni od metilnih skupin.
English: Nateglinide is excreted in the milk following a peroral dose to lactating rats.
Slovenian: Po peroralnem odmerku doječim podganam se nateglinid izloča v mleko.
English: The following agents may reduce the hypoglycaemic effect of nateglinide: diuretics, corticosteroids,
Slovenian: Hipoglikemično delovanje nateglinida lahko zmanjšajo sledeča sredstva: diuretiki, kortikosteroidi in agonisti adrenergičnih receptorjev beta2.